ClinConnect ClinConnect Logo
Search / Trial NCT06369441

Collection of Biological Specimens and Associated Health Information

Launched by OVATION.IO, INC. · Apr 11, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial aims to collect blood samples from individuals who have been diagnosed with cancer. The goal is to create a large database that researchers can use to find new ways to detect and treat cancer and other diseases. By studying these blood samples, researchers hope to learn more about how genes influence health and illness, which could lead to better treatments in the future.

To participate, individuals must be at least 18 years old and currently receiving care at one of the participating clinics. They should have a confirmed diagnosis of cancer, which includes solid tumors or blood cancers. It’s important to note that people who cannot provide informed consent or those who are currently prisoners are not eligible for this study. Participants will have the opportunity to contribute to important research that could help improve cancer care for everyone.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Are patients of participating study site clinics/clinical groups
  • Are adults (aged 18 or older)
  • Have an active cancer diagnosis with confirmatory pathology results indicating solid tumor and/or hematologic malignancy
  • Participants may have other active diagnoses with confirmatory clinical results
  • Exclusion Criteria:
  • Individuals who lack the capacity to provide informed consent
  • Individuals known to be prisoners at time of biological specimen collection

About Ovation.Io, Inc.

Ovation.io, Inc. is a pioneering clinical trial sponsor focused on advancing innovative therapeutic solutions through robust research and development. With a commitment to enhancing patient outcomes, the company leverages cutting-edge technology and data analytics to streamline clinical trial processes, ensuring efficiency and accuracy in study execution. Ovation.io collaborates closely with healthcare providers, regulatory bodies, and academic institutions to transform clinical insights into actionable strategies, ultimately aiming to bring novel treatments to market that address unmet medical needs.

Locations

Portland, Maine, United States

Patients applied

0 patients applied

Trial Officials

Pauline Gee, PhD

Study Director

VP, Clinical Affairs, Ovation.io

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported